| Title |
Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report
|
|---|---|
| Published in |
Indian Journal of Ophthalmology, September 2021
|
| DOI | 10.4103/ijo.ijo_1477_21 |
| Pubmed ID | |
| Authors |
Beatriz Endo, Silvana Bahamon, Dayron F Martínez-Pulgarín |
| Abstract |
A central retinal vein occlusion (CRVO) case in a patient developed with sudden blurred vision in some hemifield areas of his left eye, maintaining 20/20 vision 15-days after the COVID-19 vaccination. Initial retinal findings were venous dilation and tortuosity with dispersing dot hemorrhages. Fluorescein angiography (FA) and optical coherence tomography (OCT) confirmed a non-ischemic CRVO diagnosis, and a complete blood panel was requested with average results. An intravitreal steroid dose was applied. A decrease in best-corrected visual acuity (BCVA) (20/30) with more intraretinal hemorrhages was documented. An intravitreal dose of bevacizumab and oral apixaban were added with a final BCVA of 20/20 with decreased hemorrhages. There is no specific causal relationship between COVID-19 vaccines and CRVO. Without previous risk factors and positive treatment response, this case may correlate the first COVID-19 vaccine dose and the event. |
X Demographics
The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 16 | 21% |
| United Kingdom | 6 | 8% |
| India | 4 | 5% |
| Spain | 2 | 3% |
| Comoros | 1 | 1% |
| Taiwan | 1 | 1% |
| South Africa | 1 | 1% |
| Brazil | 1 | 1% |
| Turkey | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 42 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 66 | 86% |
| Practitioners (doctors, other healthcare professionals) | 6 | 8% |
| Scientists | 5 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 65 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 14% |
| Other | 6 | 9% |
| Student > Master | 6 | 9% |
| Researcher | 6 | 9% |
| Student > Ph. D. Student | 2 | 3% |
| Other | 4 | 6% |
| Unknown | 32 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 18% |
| Nursing and Health Professions | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Arts and Humanities | 2 | 3% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Other | 8 | 12% |
| Unknown | 37 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 93. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2024.
All research outputs
#465,468
of 25,706,302 outputs
Outputs from Indian Journal of Ophthalmology
#14
of 2,311 outputs
Outputs of similar age
#11,376
of 437,442 outputs
Outputs of similar age from Indian Journal of Ophthalmology
#2
of 101 outputs
Altmetric has tracked 25,706,302 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,311 research outputs from this source. They receive a mean Attention Score of 4.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.